Results 291 to 300 of about 189,801 (353)

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

open access: yesHead &Neck, Volume 47, Issue 11, Page 2939-2949, November 2025.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon   +6 more
wiley   +1 more source

Differentiation of the mononuclear phagocyte system during mouse embryogenesis:the role of transcription factor PU.1 [PDF]

open access: yes, 1999
Browne, C M   +7 more
core  

Multidisciplinary assessment of patients with extensive stage small cell lung cancer: A geriatric tumor board

open access: yes
CA: A Cancer Journal for Clinicians, EarlyView.
Humera Khurshid   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy